Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain

Stock Information for Artelo Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.